Diabetes Mellitus ( ISSN:2072-0351, E-ISSN:2072-0378) is a peer-reviewed scopus-indexed journal from 2012 to present. The publisher of this journal is Russian Association of Endocrinologists. Diabetes Mellitus committed to gathering and disseminating excellent research achievements. The journal welcomes all types of Medicine journal includes General Medicine, Internal Medicine, Endocrinology, Diabetes and Metabolism, Biochemistry, Genetics and Molecular Biology .
Submission Date
Valunteer
DM-06-08-2025-7129
Diabetes Mellitus
Gestational diabetes mellitus (GDM) is one of the most common diseases during pregnancy. To date, there is evidence showing that not all pregnant women with GDM have the same risks of developing complications. Identification of patients at increased risk of complications may be necessary given the increasing prevalence of GDM. The need for a more detailed study of GDM subtypes to identify patie
DM-06-08-2025-7128
Diabetes Mellitus
Diabetic foot syndrome is a late complication of diabetes mellitus and the main reason for non-traumatic amputations of the lower extremities in diabetic patients. Currently, standards of medical care have been developed and implemented for the treatment and prevention of this complication. At the same time, there is a lack of publications on the effectiveness of specialized care, especially at
DM-06-08-2025-7127
Diabetes Mellitus
In the treatment of diabetes mellitus (DM) for a persistent reduction in blood glucose levels it was widely used glibenclamide — a KATP channels blocker. However, its effects on cerebral circulation have been studied very little. A decrease in the functional activity of KATP channels due to their blocking by glibenclamide against the background of developed endothelial dysfunction may lea
DM-06-08-2025-7126
Diabetes Mellitus
To date, the results of Metformin, Gosogliptin and combination thereof have not been studied on a large patient population with type 2 diabetes mellitus (DM2), including comorbid patients, in real clinical settings in the Russian Federation. The aim is to evaluate the efficacy, safety, treatment adherence and satisfaction of patients with DM2 with the use of Metformin and Gosogliptin sugar-lowe
DM-06-08-2025-7125
Diabetes Mellitus
The clinical and epidemiological characteristics of diabetes mellitus (DM) and the quality of its therapy are the key prognostic dominant that determines the organizational aspects of the diabetic service. The continuous dynamic monitoring of DM has been carried out in the Russian Federation (RF) since 1996 through the activities of the Federal Register of Diabetes Mellitus (FDR). The aim of ou